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The current antiretroviral therapy HAART is effective
and life-prolonging but does not eradicate HIV-1 from
infected patients. A reduction of HIV-1 RNA levels in
the plasma in HAART-treated individuals to less than 50
copies/ml is frequently achieved but residual viremia per-
sists as detected by ultrasensitive assays. The sources of
this persistent viremia are still not fully understood but
could arise from ongoing cycles of residual viral replica-
tion and/or from the reactivation of viral expression from
latently-infected cells. These latently-infected cells con-
tain stably-integrated, transcriptionally-silent but replica-
tion-competent proviruses, thereby representing latent
reservoirs of HIV-1. They are a permanent source for
virus reactivation and could be responsible for the
rebound of plasma viral load observed after HAART
interruption.
HIV-1 transcriptional repression is crucial to the estab-
lishment and maintenance of postintegration latency.
Several elements contribute to HIV-1 transcriptional
repression including: 1) the site of integration and
mechanisms of transcriptional interference, 2) the absence
of crucial inducible host transcription factors, 3) the pre-
sence of transcriptional repressors, 4) the nucleosomal
organization of the HIV-1 promoter, 5) the epigenetic
control of the HIV-1 promoter (histone posttranslational
modifications, such as acetylation and methylation, and
DNA methylation), 6) the sequestration in an inactive
form of the cellular positive transcription elongation factor
b (P-TEFb), composed of cyclin-dependent kinase 9
(CDK9) and human cyclin T1, 7) the absence of the viral
transactivator Tat, which promotes transcription via
recruitment to the HIV-1 promoter of P-TEFb, histone-
modifying enzymes and ATP-dependent chromatin-remo-
deling complexes required for nucleosomal disruption and
transcriptional processivity. The involvement of these
elements in postintegration latency depends on the status
of activation and differentiation of the heterogeneous
CD4+ T cell populations hosting the HIV-1 reservoirs.
Further understanding of the epigenetic and non-
epigenetic mechanisms regulating HIV-1 latency and
reactivation from latency should help devise novel stra-
tegies to eliminate latent HIV-1 infection or to restrict
the latent pool to a size bearable by the host immune
system.
Published: 25 May 2012
doi:10.1186/1742-4690-9-S1-I10
Cite this article as: Van Lint: Molecular control of HIV - 1
postintegration latency: implications for therapeutic strategies.
Retrovirology 2012 9(Suppl 1):I10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Gosselies Campus, Charleroi, Belgium
Van Lint Retrovirology 2012, 9(Suppl 1):I10
http://www.retrovirology.com/content/9/S1/I10
© 2012 Van Lint; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
